Navigation Links
Progeniq Joins Microsoft in Bio IT Alliance
Date:9/25/2007

Empowers Life Sciences Community with accelerated BioInformatics

SINGAPORE, Sept. 26 /Xinhua-PRNewswire/ -- Microsoft Corp., announced the initiation of Progeniq Pte Ltd, a leader in reconfigurable computing applications headquartered in Singapore, into the BioIT Alliance today. The BioIT Alliance is a cross-industry group working to integrate science and technology to accelerate the pace of drug discovery and realize the potential of personalized medicine. The early focus of the Alliance has been to address the data-capture and data-integration challenges that face the industry. Additional information about the BioIT Alliance can be found at http://www.bioitalliance.org .

The Progeniq BioBoost provides hardware accelerated processing for the most computationally intensive applications in Bioinformatics -- NCBI BLAST, Smith Waterman, HMMer and ClustalW. Processing these protein searches will be cut from months to days, and weeks to hours and minutes.

"The life sciences offer one of the best opportunities for information technology to accelerate the pace of drug discovery and development," said Rudy Potenzone, Bio IT Alliance Manager at Microsoft. "Progeniq's collaboration in the Alliance will be a tremendous boost in Bioinformatics data-processing and discoveries in the life science industry."

By utilizing Field Programmable Gate Array (FPGA) technology, the processor is able to 'rewire' itself on the fly according to the application that needs to be accelerated. This results in further energy savings, as the FPGA consumes as little as 5 watts of power from the USB, as compared to the racks of servers and cooling required that it replaces.

"Progeniq is delighted to collaborate with Microsoft and Life Science companies in the Bio IT Alliance," said Darran Nathan, Progeniq's Chief Executive Officer. "We are confident that more users will benefit from the speedups from the BioBoost, and more in the life science industry can enjoy its benefits."

The BioBoost Accelerated suite for Bioinformatics is available for immediate shipment at USD3,000 for first time buyers. Visit http://www.progeniq.com/products/offer.htm for details .

About Progeniq Pte Ltd

Progeniq is a leader in reconfigurable computing applications for High Performance Computing (HPC) industries, with its BioBoost line of products for the life sciences industry already adopted by institutes worldwide. Today Progeniq continues to reinvent the way computing is done by leveraging on the Boost Platform to introduce reconfigurable computing into new compute- intensive industries, increasing the efficiency of computing systems, boosting up performance and slashing cost.

About the BioIT Alliance

Formed in 2006, the BioIT Alliance is a cross-industry group working to integrate science and technology in order to accelerate the pace of drug discovery and realize the potential of personalized medicine. Founding members include Accelrys Software Inc., Affymetrix, Inc., Agilent Technologies Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corporation, Geospiza Inc., Hewlett-Packard Development Company, L.P., Illumina Inc., InterKnowlogy, Microsoft Corporation, Sun Microsystems Inc., The Scripps Research Institute, VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. Additional information about the BioIT Alliance can be found on the BioIT Alliance Web site at http://www.bioitalliance.org .

Contact Information:

Progeniq Pte Ltd

KUMAR Senthil or CHUA Teck Hiong

Email: senthil@progeniq.com / teckhiong@progeniq.com

Tel: +65-6779-0930

Fax: +65-6872-4860

Microsoft Corp.

POTENZONE Rudy

Email: rudolphp@microsoft.com

Tel: +1-425-703-1354

Fax: +1-425-936-7329


'/>"/>
SOURCE Progeniq Pte Ltd
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Chemical-petroleum executive joins Virent Energy board
2. Schneider National exec joins TrafficCast board
3. Doyle joins governors in support of stem cell bill
4. Genomics researcher Hood joins NimbleGen board
5. Fergus joins Baird Venture Partners, Caden Bio
6. Meier joins Broadlook Technologies as COO
7. Prodesse joins forces with Invitrogen
8. Wisconsin joins price-fixing suit vs. D-RAM makers
9. Napier joins board of Third Wave Technologies
10. Schmidt rejoins Renaissance Learning
11. Tommy Thompson joins drug company as advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... ... 09, 2017 , ... The award-winning American Farmer television series will feature 3 ... airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ten ... to continue to feed a growing nation. At the same time, many of our ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):